News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Abiraterone made available earlier for men in Scotland
Abiraterone has been made available on the NHS in Scotland for men with advanced prostate cancer before treatment with chemotherapy.
Scientists uncover four different types of bowel cancer
Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.
Gene may explain elephants’ surprisingly low cancer rate
Scientists believe they may be able to explain elephants’ low cancer rates – providing intriguing clues for preventing cancer in humans.
New Head of Cancer Therapeutics sets sights on cancers of unmet need
Dr Rajesh Chopra, a global leader in the development of molecularly targeted cancer drugs, will spearhead the ICR's world-leading work in cancer therapeutics.
Major study finds five new genetic variants linked to brain cancer
The biggest ever study of DNA from the most common form of brain cancer has discovered five new genetic variants associated with the disease.
HRT safe and perhaps beneficial in women treated for ovarian cancer, major trial shows
Women with the commonest type of ovarian cancer can safely take hormone replacement therapy according to results from a 24-year, phase III international trial.
Fewer, larger radiotherapy doses prove effective for prostate cancer patients
Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to research presented at the 2015 European Cancer Congress.
Understanding why some men still die from testicular cancer
Since the early 1970s survival for testicular cancer has risen continuously, and current cure rates are a remarkable 96%. Research attention is now focused on the minority of patients who do not survive.
Tom Bowdidge Foundation gives £250,000 for rare cancer research
The Tom Bowdidge Foundation has pledged to give more than £250,000 to support research into a rare form of cancer called desmoplastic small round cell tumour.
Rare variants are not so rare after all, new study finds
Scientists from the ICR have shown that each person in the UK has an average of 160 rare genetic variants.
Sir Kenneth Stowe, former ICR Chairman and senior civil servant, dies
Sir Kenneth Stowe, who was Chairman of the ICR in the eighties and nineties, has died.
Professor Nazneen Rahman featured in list of London’s most influential people
For the second consecutive year, Professor Nazneen Rahman has featured in the London Evening Standard’s ‘Power1000’ list of the most influential people in London.
